Dx
is headquartered in Seoul, Seoul Teugbyeolsi. Yong Gu Lee is the CEO of Dx . Dx has 1 followers on Owler. Dx has an estimated revenue of <$1M and an estimate of less <10 employees.Dx
is headquartered in Seoul, Seoul Teugbyeolsi. Yong Gu Lee is the CEO of Dx . Dx has 1 followers on Owler. Dx has an estimated revenue of <$1M and an estimate of less <10 employees.
CEO
Yong Gu Lee
News
Aug 10, 2026
centralcharts
Press Release: Dx : Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors"
Jul 06, 2026
Acrofan
Dx : Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, 'Focused Discussions on Overseas Out-Licensing Deals'
Apr 24, 2026
Korea Biomedical Review
Dx : Dx&Vx affiliate Oxford Vacmedix reports phase 1 success for cancer vaccine OVM-200
Mar 04, 2026
Korea Biomedical Review
Dx : Dx&Vx recruits small-molecule and gene therapy specialists to boost R&D
Feb 03, 2026
Korea Biomedical Review
Dx : Dx&Vx files patent for self-assembly nanoparticle technology for NGS
Jan 29, 2026
Korea Biomedical Review
Dx : Dx&Vx moves closer to mRNA platform license-out with European partner
Sep 12, 2025
Korea Biomedical Review
Dx : Dx&Vx introduces Yikon Genomics technology to enhance infertility diagnostics
Jul 31, 2025
Korea Biomedical Review
Dx : Dx&Vx inks 1st global licensing deal for mRNA cancer vaccine
Jun 09, 2025
Korea Biomedical Review
Dx : Dx&Vx strikes 1st deal with global pharma to test mRNA platform
May 29, 2025
Benzinga
Dx : Dx&Vx Accelerates Development of Universal COVID-19 Vaccine